Key Statistics for IRIX
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IRIX
- Net Income (M/USD)
IRIDEX Corporation provides semiconductor-based laser systems used to treat eye disease and skin lesions. The Company's products are sold around the world. IRIDEX markets its IRIS Medical products to the ophthalmic market, IRIDERM to the dermatological market, and Light Solutions to the research market.
More Company Profile & Key Executives for IRIX
|William M MooreChairman/President/CEO||James H MackanessCFO/COO|
|Timothy D BuckleyVP:Marketing North America||Ronald T SteckelVP:Operations|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.